Media

How AI, blockchain, and big data can reduce drug development costs Pharmaphorum Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s no secret that drug prices are a controversial issue. Just last week, US President Trump called high drug prices an “injustice” and […]

Read more

How AI Is Transforming The Future Of Healthcare Forbes Technology Council Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. I recently wrote about five technologies that are shaping the future of healthcare. One of these technologies — artificial intelligence — holds particular potential for improving medical care […]

Read more

Innoplexus strengthens its global leadership team with accomplished leaders- appoints Silke Otte as Chief Marketing Officer and Graeme Mcfarlane as the Chief Commercial Officer Silke Otte brings more than 22 years of IT and financial services industry experience in digital channels, advertising, customer relationship management (CRM), campaign management, and concept development. Prior to joining Innoplexus, […]

Read more

Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence Ganti joins Innoplexus as CEO, Americas Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected […]

Read more

Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th July 2017, in Berlin, Germany. The panel discussion is around “From Past Learning to Predictive Future” at 13:45 CET on Friday at Deutsche Telekom Hauptstadtrepräsentanz Französische Straße 33a-c, […]

Read more

As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for life sciences and pharmaceutical industries. A lot still relies upon data while conducting research which is mostly done through traditional methods. As many top notch business […]

Read more

Innoplexus unveiled iPlexus TM at Bio-IT, 2017, Boston. iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and […]

Read more

3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information is the new currency of innovation. With data flowing from countless new sources every day, the opportunities to dig in and learn more about the world around us have never been greater. Sometimes […]

Read more

Are Indian Tech Start-ups Robust Enough To Run Fast With Nation’s Digital Drive? The Zomato security breach puts a question mark on the information handling ability of start-ups The digital drive in India has altered the functioning of the industrial sector and put it on a fast track. In today’s cut-throat competition, every small or […]

Read more

  Excited to announce that Innoplexus is a gold sponsor of Bio-IT World Conference & Expo which is a 3 day event being held from 23rd May to 25th May 2017 at the Seaport World Trade Center in Boston, United States Of America. This event will feature various sectors from the Bioinformatics industry. Our Founder […]

Read more

Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexusᵀᴹ platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexusᵀᴹ. Doctors and researchers will be able to gain insights into the latest […]

Read more

Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexusTM, and invest in marketing.

Read more
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search